Nifekalant: A New Option for Pre-Excited Atrial Fibrillation With a High-Risk Accessory Pathway

Atrial fibrillation along with accessory pathway–induced ventricular pre-excitation may be life-threatening due to the high risk of developing severe hypotension, ventricular fibrillation, and sudden death. We demonstrate nifekalant as an effective agent in the pharmacological cardioversion of atria...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Liu, Yu, Liuyu, Chen, Zhijian, Zhang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Mini-Focus Issue: Electrophysiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298543/
https://www.ncbi.nlm.nih.gov/pubmed/34317211
http://dx.doi.org/10.1016/j.jaccas.2019.10.042
Descripción
Sumario:Atrial fibrillation along with accessory pathway–induced ventricular pre-excitation may be life-threatening due to the high risk of developing severe hypotension, ventricular fibrillation, and sudden death. We demonstrate nifekalant as an effective agent in the pharmacological cardioversion of atrial fibrillation with high-risk accessory pathways. (Level of Difficulty: Intermediate.)

Ejemplares similares